Erratum for the Research Article “Extracellular vesicle–mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice” | Science Translational Medicine

In the Research Article “Extracellular vesicle–mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice” by X. Pan et al., a competing interest was not disclosed in the initially published version. The following sentence was added the “Competing interests” section of the Acknowledgments: “M.H. has a financial interest in ExoDel, Inc., a company that options technology evaluated in this research and that could benefit from the results of the research.”